Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

familial Mediterranean fever News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent study highlights the diagnosis of fibrillary glomerulonephritis as a potential indicator of atypical familial Mediterranean fever in patients with ulcerative colitis. This finding may enhance understanding of the disease's manifestations and improve patient management.

A study highlights the use of Instagram as an educational tool for raising awareness about familial Mediterranean fever over a 33-month period. This innovative approach may enhance patient engagement and knowledge dissemination.

A recent study published in PubMed evaluates the effectiveness of canakinumab in achieving full disease control in patients with familial Mediterranean fever. The findings contribute valuable real-world data to the understanding of treatment outcomes for this rare condition.

A study evaluates the real-world efficacy and safety of Anakinra and Canakinumab in pediatric patients with colchicine-resistant familial Mediterranean fever. The findings provide insights into drug retention and treatment outcomes in this specific patient population.

A rare case report highlights the association of temporomandibular joint ankylosis with psoriasis and familial Mediterranean fever. This finding may provide insights into the complex interplay between these conditions.

Not rare diseases news,news about your rare disease.

Earlier

A recent study highlights the diagnosis of fibrillary glomerulonephritis as a potential indicator of atypical familial Mediterranean fever in patients with ulcerative colitis. This finding may enhance understanding of the disease's manifestations and improve patient management.

A study highlights the use of Instagram as an educational tool for raising awareness about familial Mediterranean fever over a 33-month period. This innovative approach may enhance patient engagement and knowledge dissemination.

A recent study published in PubMed evaluates the effectiveness of canakinumab in achieving full disease control in patients with familial Mediterranean fever. The findings contribute valuable real-world data to the understanding of treatment outcomes for this rare condition.

A study evaluates the real-world efficacy and safety of Anakinra and Canakinumab in pediatric patients with colchicine-resistant familial Mediterranean fever. The findings provide insights into drug retention and treatment outcomes in this specific patient population.

A rare case report highlights the association of temporomandibular joint ankylosis with psoriasis and familial Mediterranean fever. This finding may provide insights into the complex interplay between these conditions.

Not rare diseases news,
news about your rare disease.